XTX Topco’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
+28,839
New +$389K 0.01% 2623
2026
Q1
Sell
-155,944
Closed -$2.19M 4284
2025
Q4
$2.19M Buy
+155,944
New +$2.19M 0.06% 506
2024
Q3
Sell
-36,525
Closed -$557K 2509
2024
Q2
$557K Buy
+36,525
New +$524K 0.05% 606
2023
Q2
Sell
-29,400
Closed -$335K 1761
2023
Q1
$335K Buy
+29,400
New +$317K 0.07% 565
2021
Q4
Sell
-15,590
Closed -$203K 952
2021
Q3
$203K Buy
+15,590
New +$208K 0.07% 504

Other funds holding RDY

XTX Topco's RDY Position: Q2 2026 in Review

XTX Topco opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 28,839 shares worth $418K. The stake represents 0.01% of the portfolio and ranks #2623 among its holdings. This is a return to the name: XTX Topco previously reported a position in RDY as recently as Q4 2025.

XTX Topco first reported a position in RDY in Q3 2021 and has held it in 5 quarters since. The position peaked at $2.19M in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • XTX Topco held 28,839 shares of Dr. Reddy's Laboratories worth $418K as of Q2 2026.
  • Dr. Reddy's Laboratories was a new XTX Topco position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2623 holding.
  • XTX Topco first reported a position in Dr. Reddy's Laboratories in Q3 2021 and has held it in 5 quarters since.
  • XTX Topco's Dr. Reddy's Laboratories position peaked at $2.19M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.